TCIM
FURX

TIAA CREF Investment Management’s FURIEX PHARMACEUTICALS INC COM STK (DE) FURX Stock Holding History

TIAA CREF Investment Management’s Portfolio FURX Stock Details FURX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-28,705
Closed -$3.05M – 3173
2014
Q2 		$3.05M Buy
28,705
+1,212
+4% +$119K ﹤0.01% 2031
2014
Q1 		$2.39M Sell
27,493
-1,320
-5% -$102K ﹤0.01% 2131
2013
Q4 		$1.21M Hold
28,813
– – ﹤0.01% 2560
2013
Q3 		$1.27M Sell
28,813
-2,460
-8% -$102K ﹤0.01% 2477
2013
Q2 		$1.06M Buy
+31,273
New +$1.1M ﹤0.01% 2545

TIAA CREF Investment Management's FURX Position: Q3 2014 in Review

TIAA CREF Investment Management sold out of FURIEX PHARMACEUTICALS INC COM STK (DE) (FURX) in Q3 2014, closing a stake of 28,705 shares — an estimated $3.05M sold.

TIAA CREF Investment Management first reported a position in FURX in Q2 2013 and held it in 5 quarters. The position peaked at $3.05M in Q2 2014. 0 funds tracked by Wall St. Rank hold FURX as of Q3 2014.

  • TIAA CREF Investment Management reported no remaining FURIEX PHARMACEUTICALS INC COM STK (DE) position as of Q3 2014 after selling out during the quarter.
  • TIAA CREF Investment Management sold 28,705 FURIEX PHARMACEUTICALS INC COM STK (DE) shares in Q3 2014, an estimated $3.05M.
  • TIAA CREF Investment Management first reported a position in FURIEX PHARMACEUTICALS INC COM STK (DE) in Q2 2013 and held it in 5 quarters.
  • TIAA CREF Investment Management's FURIEX PHARMACEUTICALS INC COM STK (DE) position peaked at $3.05M in Q2 2014.
  • 0 funds tracked by Wall St. Rank held FURIEX PHARMACEUTICALS INC COM STK (DE) as of Q3 2014.

Based on TIAA CREF Investment Management's 13F filing for Q3 2014, filed 13 Nov 2014.